Comprehensive Respiratory Virus Panel Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.
| Features | Performance |
| Coverage uniformity (0.2X): | |
| Reproducibility (%): | |
| Sensitivity (%): | |
| On Target Ratio (%): |
| Parameter | Description |
| Text: | |
| Text: | |
| Target Size: | |
| Mutation types: | |
| Sample type: | |
| Platform compatibility : |
Demonstration of outstanding coverage uniformity achieved with the G2M Pan-Cancer CGP Panel:
Greater than 0.2X mean coverage is observed for >99% of targets. The genomic DNA libraries from blood and FFPE tissues (n=64) were enriched using the G2M Pan-Cancer NGS Panel and sequenced on a NovaSeq system using 2 x 150 paired-end reads. The data represents near-complete uniform coverage (~100%) across all samples at 0.2X, 10X, and 30X thresholds. This high level of uniformity indicates that the probe design is well optimized, enabling targeted NGS assays to consistently deliver high-confidence and reproducible results.
Consistent fold 80 base penalty across sample types highlights the analytical strength of the G2M PanCancer Panel:
Fold 80 base penalty across both FFPE (blue bar) and blood-derived (cyan bar) samples. The G2M Pan-Can CGP Panel demonstrates a fold 80 base penalty below 1.3, reflecting exceptional coverage uniformity across target regions. This low value indicates that only 1.3× the average sequencing depth is required to achieve 80% coverage at the desired threshold, minimizing over-sequencing and ensuring efficient, balanced read distribution affirming the robustness of the data quality.
| Commercial Name | Cat No. | Pack Size | Platform |
|---|---|---|---|
| Comprehensive Respiratory Virus Panel | G710021-1 | 24 T | Illumina |
| G710021-2 | 96 T | Illumina | |
| G710021-3 | 96 T - EZY | Illumina – EZY | |
| Comprehensive Respiratory Virus Panel | G710021-4 | 24 T | MGI |
| G710021-5 | 96 T | MGI | |
| G710021-6 | 96 T – EZY | MGI – EZY | |
| Comprehensive Respiratory Virus Panel | G710021-7 | 24 T | Aviti |
| G710021-8 | 96 T | Aviti | |
| G710021-9 | 96 T – EZY | Aviti – EZY | |
| Comprehensive Respiratory Virus Panel | G710021-10 | 24 T | Thermo |
| G710021-11 | 96 T | Thermo | |
| G710021-12 | 96 T – EZY | Thermo – EZY |
Download useful documents and technical information for Comprehensive Respiratory Virus Panel.
Since its inception in 2016, Genes2me has been constantly striving towards setting a benchmark in the diagnostics space by introducing premium quality (Made in India) diagnostic kits which are CE-IVD, ISO-13485:2016, and ISO 9001:2015 certified, assuring our clients of unparalleled quality and compliance with international standards.
All products listed in the catalogue are the products of Genes2Me Private Limited. Apart from that, all other product names, trademarks and logos wherever used in the catalogue are the property of their respective owners.
© 2025 Genes2me. All rights reserved.
